参考文献/References:
[1] 昝海波,王波,郭志勇.CEA 结合CA199 检测在良、恶性胸腹腔积液鉴别诊断中的意义[J].中国临床实用医学 ,2016,7(6):80-82. ZAN Haibo,WANG Bo,GUO Zhiyong. Significance ofCEA combined with CA199 in differential diagnosis ofbenign and malignant pleural and peritoneal effusion[J].China Clinical Practical Medicine ,2016,7(6):80-82.
[2] 吴江,汪宏良.铁蛋白与CA125 联合检测在良、恶性腹水鉴别诊断中的临床意义[J].中国现代医学杂志,2014,24(36):35-38. WU Jiang, WANG Hongliang. Clinical significanceof tumor markers of tumor ferritin,CA125 combineddetection in benign and malignant ascites differentialdiagnosis [J]. China Journal of Modern Medicine, 2014,24(36):35-38..
[3] 孙晓敏,董卫国,高礼层,等.恶性腹水中可溶性CD44v6 的检测及意义[J].中华检验医学杂志,2003,26(11):662-664. SUN Xiaomin, DONG Weiguo, GAO Liceng, ea al.Detection of sCD44v6 in malignant ascites [J]. ChineseJournal of Laboratory Medicine,2003,26(11):662-664.
[4] 孙玉真, 孙前进. CD44V6, ADA, IFN-γ 联合检测在胸腹水鉴别中的临床应用[J]. 中国实用医药,2014,9(21):5-7. SUN Yuzhen, SUN Qianjin. Clinical application ofcombined detection of CD44v6, ADA, and IFN-γ inpleuroperitoneal effusions [J]. China Practical Medical,2014,9(21):5-7.(上接55 页)
[5] 周萍,郭炫,陈葳,等.肿瘤标志物联合检测在胸腹水性质鉴别中的临床应用[J].现代肿瘤医学,2014,22(3):664-666. ZHOU Ping, GUO Xuan, CHEN Wei, et al. Clinicaldetection of tumor markers in differential diagnosisof pleural effusion and ascites [J]. Journal of ModernOncology, 2014, 22(3):664-666.
[6] 赵连爽,云科,董西华.胃癌患者血清中CA72-4,CEA 和CA19-9 水平及其与病理特征的相关性[J].中国医科大学学报,2014,43(3):259-262, 27. ZHAO Lianshuang, YUN Ke, DONG Xihua. TheCorrelation between CA72-4, CEA and CA19-9Expression in patients with gastric carcinoma andpathological features[J]. Journal of China MedicalUniversity, 2014, 43(3):259-262,274.
[7] 韩丹,陈志飞,邱鸣.CA125 在肺结核、结核性胸膜炎与肺癌鉴别诊断中的价值[J].临床肺科杂志,2008,13(9):1160-1161.HAN Dan, CHEN Zhifei, QIU Ming. The impact ofcontent of serum CA125 on the diagnosis of pulmonarytuberculosis、tuberculous pleurisy and lung cancer[J]. Journal of Clinical Pulmonary Medicine, 2008,13(9):1160-1161.
[8] 于华, 朱文茹, 孙术红, 等.AM, CYFRA21-1,NSE 和CEA 联合检测对恶性与结核性胸腔积液的鉴别诊断价值[J].标记免疫分析与临床,2005,12(1):4-6. YU Hua, ZHU Wenru, SUN Shuhong, et al. Combineddetection of AM, CYFRA21-1, NSE and CEA levels inpleural effusion for differentiation of malignant fromtuberculous pleural effusion [J]. Labeled Immunoassaysand Clinical Medicine 2005, 12(1) :4-6.
[9] 佟威威, 佟广辉, 王婧, 等.CYFRA21-1, NSE,SCCA 和CRP 在肺癌诊断中的应用[J].中国免疫学杂志,2015,31(3):396-400. TONG Weiwei, TONG Guanghui, WANG Jing,et al. Value of CYFRA21-1,NSE,CRP and SCCAin diagnosis of lung cancer [J]. Chinese Journal ofImmunology,2015,31 (3):396-400.